- Home
- SGC vs SMTI Comparison
SGC vs SMTI Comparison
Compare SGC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- SMTI
- Stock Information
- Founded
- SGC 1920
- SMTI 1982
- Country
- SGC United States
- SMTI United States
- Employees
- SGC N/A
- SMTI N/A
- Industry
- SGC Apparel
- SMTI Medical/Dental Instruments
- Sector
- SGC Consumer Discretionary
- SMTI Health Care
- Exchange
- SGC Nasdaq
- SMTI Nasdaq
- Market Cap
- SGC 281.4M
- SMTI 266.7M
- IPO Year
- SGC N/A
- SMTI N/A
- Fundamental
- Price
- SGC $10.36
- SMTI $32.15
- Analyst Decision
- SGC Strong Buy
- SMTI Strong Buy
- Analyst Count
- SGC 2
- SMTI 2
- Target Price
- SGC $19.00
- SMTI $48.50
- AVG Volume (30 Days)
- SGC 44.8K
- SMTI 20.1K
- Earning Date
- SGC 05-08-2025
- SMTI 05-14-2025
- Dividend Yield
- SGC 5.35%
- SMTI N/A
- EPS Growth
- SGC 35.19
- SMTI N/A
- EPS
- SGC 0.73
- SMTI N/A
- Revenue
- SGC $565,676,000.00
- SMTI $86,672,425.00
- Revenue This Year
- SGC $4.67
- SMTI $23.68
- Revenue Next Year
- SGC $5.01
- SMTI $5.80
- P/E Ratio
- SGC $14.34
- SMTI N/A
- Revenue Growth
- SGC 4.12
- SMTI 33.36
- 52 Week Low
- SGC $9.11
- SMTI $25.86
- 52 Week High
- SGC $21.80
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- SGC 38.87
- SMTI 55.26
- Support Level
- SGC $10.10
- SMTI $30.54
- Resistance Level
- SGC $10.64
- SMTI $32.78
- Average True Range (ATR)
- SGC 0.40
- SMTI 1.02
- MACD
- SGC 0.07
- SMTI 0.20
- Stochastic Oscillator
- SGC 29.91
- SMTI 76.20
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.